Who Owns Can-Fite Biopharma Stock?
NYSE: CANFHealthcareBiotechnologyUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 1.66%
- Held by insiders
- 0.00%
- Institutional holders
- 9
- Institutions 1.7%
- Insiders 0.0%
- Public and other 98.3%
Who owns Can-Fite Biopharma stock?
Institutional investors own about 1.7% of Can-Fite Biopharma's shares, spread across 9 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 0.00% of CANF.
The largest institutional holders are Citadel Advisors Llc (1.07%), Rhumbline Advisers (0.58%) and Fifth Third Bancorp (0.00%). Together, the top 8 institutions control 1.6% of shares outstanding. In their latest filings, 0 of the top 8 institutions increased their CANF positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of CANF
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Citadel Advisors Llc | 32.53K | 1.07% | -4.7% |
| Rhumbline Advisers | 17.43K | 0.58% | -16.6% |
| Fifth Third Bancorp | 150 | 0.00% | 0.0% |
| Wells Fargo & Company | 59 | 0.00% | -52.8% |
| Activest Wealth Management | 10 | 0.00% | 0.0% |
| Avion Wealth | 5 | 0.00% | 0.0% |
| Morgan Stanley | 1 | 0.00% | 0.0% |
| TD Waterhouse Canada Inc. | 1 | 0.00% | 0.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of CANF
| Fund | Shares | % Held |
|---|---|---|
| Blackstone Alternative Investment Fd.s-Blackstone Alternative Multi-St | 50 | 0.00% |
Frequently asked questions
Who is the largest shareholder of Can-Fite Biopharma?
Citadel Advisors Llc is the largest institutional shareholder of CANF, owning 1.07% of shares outstanding (32.53K shares) as of its latest 13F filing.
What percentage of Can-Fite Biopharma is owned by institutions?
Institutions own about 1.7% of CANF shares and 1.7% of the public float.
How much of Can-Fite Biopharma do insiders own?
Insiders, such as officers and directors, own about 0.00% of CANF shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.